BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 1084106)

  • 1. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
    Guimbretére J
    Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

  • 5. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of von Willebrand's disease.
    Meyer D
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):229-33. PubMed ID: 316575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Ketsueki; 1977 May; 18(5):575-86. PubMed ID: 333144
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
    Stites DP; Hershgold EJ; Perlman JD; Fudenberg HH
    Science; 1971 Jan; 171(3967):196-7. PubMed ID: 5312959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

  • 12. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of factor VIII levels after adrenalin in classic hemophilia and von Willebrand's disease (vWd).
    Eyster ME; Ballard JO; Prager D
    Thromb Haemost; 1978 Jun; 39(3):657-62. PubMed ID: 309190
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.
    Tokunaga N; Inoue C; Sakata T; Kagawa K; Abe M; Takamatsu N; Nakao T; Doi T
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):474-6. PubMed ID: 26523912
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.